Telix Pharmaceuticals Ltd (ASX: TLX) shares are charging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $15.10. In early morning trade on Tuesday, shares are changing hands for $15.48 apiece, up 2.5%.

For some context, the ASX 200 is down 0.6% at this same time.

Telix shares have been on fire since plumbing a one-year closing low of $8.63 on 16 February. Indeed, with today’s intraday lift factored in, the ASX 200 healthcare share has surged 79.4% since that low.

Here’s what’s catching investor interest today.

Telix shares jump on revenue growth

Telix shares are outperforming following the release of the company’s second-quarter results (Q2 2026), covering the six months to 30 June.

Highlights included a 21% year-on-year revenue boost to US$247 million (AU$353 million). Second-quarter revenue was up 7% from the prior quarter.

The company’s Precision Medicine segment brought in US$202 million of that quarterly revenue, a 30% increase from Q2 2025 and up 9% from last quarter.

The quarter also saw Telix finalise its strategic collaboration with antibody discovery and development platform developer Regeneron. The two companies will now work to jointly develop and commercialise next-generation radiopharmaceutical therapies.

Looking at what could impact Telix shares in the months ahead, the company forecasts that full-year 2026 revenue and other income will exceed US$1 billion. Revenue was reported to be tracking in line with the upper end of Telix’s 2026 guidance of US$950 million to US$970 million, plus US$40 million non-refundable other income from Regeneron.

On the expenditure side, Telix increased its full-year 2026 R&D expenditure guidance to US$230 million to US$270 million. The company said the increased spend will support the advancement of high-value clinical programs beyond its original R&D forecast.

What did management say?

Commenting on the results helping boost Telix shares today, CEO Christian Behrenbruch said, “We delivered another quarter of growth with US dose volumes increasing 7% during the quarter, driven by growing demand for Gozellix and continued strength across our PSMA7 imaging portfolio.”

Behrenbruch added:

This performance underscores the strength of our differentiated two-product PSMA imaging strategy and reinforces Telix’s market leadership, built on clinical differentiation, supply chain resilience and commercial execution. During the quarter, we achieved key regulatory, commercial and clinical milestones across both our Precision Medicine and Therapeutics businesses.

Looking ahead, Behrenbruch concluded:

We are tracking in line with the upper end of our FY 2026 revenue guidance and are investing further in R&D to accelerate a number of high-value programs that have the potential to create significant future growth and shareholder value.

The post Up 79% since February, why are Telix shares jumping higher again on Tuesday? appeared first on The Motley Fool Australia.

More reading

• Top 3 ASX healthcare stocks to watch
• Telix Pharmaceuticals: Q2 2026 revenue jumps 21%
• These are the 10 most shorted ASX shares
• Down 9%: Is the rebound over for Telix shares?
• These are the 10 most shorted ASX shares

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The WAM Income Maximiser Ltd (ASX: WMX) share price is in focus after the company announced a fully franked monthly dividend of 0.66 cents per share, payable at the end of October 2026.

What did WAM Income Maximiser report?

• Dividend of 0.66 cents per share, fully franked
• Record date: 20 October 2026
• Ex-dividend date: 19 October 2026
• Payment date: 30 October 2026
• Dividend covers the October 2026 period
• Dividend Reinvestment Plan (DRP) available, no discount applied

What else do investors need to know?

WAM Income Maximiser continues its established pattern of delivering monthly, fully franked dividends with this latest announcement. The dividend is set at 0.66 cents per share, in line with recent payments, offering ongoing income to shareholders.

Investors can choose to reinvest their dividends via the company’s Dividend Reinvestment Plan (DRP). The DRP will operate at no discount, with the reinvestment price based on the volume weighted average market price across the four trading days from the ex-dividend date.

It’s important to note that shareholders need to confirm their DRP participation by 5pm on Thursday, 22 October 2026, if they wish to reinvest their dividends.

What’s next for WAM Income Maximiser?

WAM Income Maximiser remains focused on delivering regular, tax-effective income to shareholders through monthly, fully franked dividends. The ongoing DRP provides flexibility for investors seeking to accumulate more shares.

Looking ahead, the company will likely maintain its dividend strategy while monitoring market conditions and the performance of its investment portfolio.

WAM Income Maximiser share price snapshot

Over the past 12 months, WAM Income Maximiser shares have risen 4%, outperforming the S&P/ASX All Ords Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post WAM Income Maximiser announces fully franked October 2026 dividend appeared first on The Motley Fool Australia.

More reading

• Andean Silver Bonanza silver-gold unearthed at Cerro Bayo’s Juanita prospect
• Ophir High Conviction Fund announces FY26 unfranked distribution
• 5 ASX All Ords shares that ripped 200% to 400% in FY26

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The HUB24 Ltd (ASX: HUB) share price is in focus today after the company announced record net inflows of $18.9 billion in FY26, up 20% on the prior comparable period (pcp), and total Funds Under Administration (FUA) hitting $164.3 billion, up 20% on pcp.

What did HUB24 report?

• Platform net inflows reached a record $18.9 billion, up 20% on pcp (excluding large migrations)
• Total FUA stood at $164.3 billion as at 30 June 2026, up 20% on pcp
• Platform FUA increased to $139.5 billion, up 24% on pcp
• PARS FUA was $24.8 billion, up 5% on pcp
• Active advisers using the platform rose to 5,649, up 11% on pcp
• Class Super accounts increased by 5% to 226,767; NowInfinity document orders rose 15%

What else do investors need to know?

The HUB24 Platform was ranked first for both quarterly and annual net inflows for the tenth consecutive quarter and retained the highest Net Promoter Score (NPS) in prominent industry surveys. Market share increased to 9.9% as at 31 March 2026, making HUB24 the sixth largest platform by FUA in Australia.

HUB24 continued to invest in innovation, launching its lifetime super solution in partnership with TAL, which expanded the range of retirement options for advisers and clients. The company also enhanced its Class and NowInfinity offerings, introducing AI-driven transaction matching and improved identity verification features.

During the quarter, 36 new licensee agreements were signed, reflecting HUB24’s expanding reach, and the number of advisers using its platform grew by 11% year on year.

What’s next for HUB24?

Looking ahead, HUB24 aims to build on its momentum by further investing in product innovation and adviser support. Plans include the pilot launch of ‘myhub’, an AI-powered advice ecosystem, in the first half of FY27.

Structural industry trends, such as strong demand for financial advice and evolving superannuation regulations, are expected to underpin ongoing growth. HUB24 says it is well positioned with a solid pipeline of new opportunities across both new and existing relationships.

HUB24 share price snapshot

Over the past 12 months, HUB24 shares have declined 18%, trailing the S&P/ASX 200 Index (ASX: XJO), which has risen 1% over the same period.

View Original Announcement

The post HUB24 earnings: Record $18.9bn net inflows lift FUA appeared first on The Motley Fool Australia.

More reading

• Contact Energy June 2026 earnings: Sales rise, renewables progress
• Telix Pharmaceuticals: Q2 2026 revenue jumps 21%
• 4 ASX share tips from 4 brokers, for returns better than 40%
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24. The Motley Fool Australia has recommended Hub24. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.